| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |